Body Image Concerns, Maladaptive Eating Behaviors, and Weight Status in Children with ADHD: Are there Differences between Children Treated with and without Medication and Healthy Controls?
摘要
The objective of this study was to evaluate whether there were associations between being treated with medication for ADHD, body image concerns, maladaptive eating behaviors, and weight status in a national sample of children ages 6 to 17 years diagnosed with Attention Deficit/Hyperactivity Disorder (ADHD). The study also assessed whether there were differences in body image concerns, maladaptive eating behaviors, and weight status between children with ADHD treated with and without medication and matched healthy controls.
MethodParticipants were parents of 4,819 children ages 6 to 17 years (64.5% boys) diagnosed by a doctor or other health care provider with ADHD and 9,025 healthy control children ages 6 to 17 years (60.5% boys) from the 2022 National Survey of Children’s Health.
ResultsAfter controlling for sociodemographic variables, currently taking medication for ADHD was significantly associated with more fasting (Odds Ratio = 1.32; p < .001), binge eating (Odds Ratio = 1.26; p < .05), picky eating (Odds Ratio = 1.21; p < .001), and low interest in food (Odds Ratio = 1.77; p < .001). Above and beyond the control variables, currently taking medication for ADHD was associated with greater parental concerns about their child’s body weight being too low (Odds Ratio = 1.56; p < .001). Parents of children in the healthy control group reported fewer maladaptive eating behaviors and body image concerns for their children compared to parents of children with ADHD on and off medication (p < .001).
ConclusionsThese findings suggest children with ADHD, regardless of medication status, may be more likely to manifest maladaptive eating behaviors and body image concerns than children without a physical and mental health condition and may benefit from routine assessment of maladaptive eating behaviors and body weight concerns and when warranted the implementation of interventions that address weight loss as a potential barrier of stimulant medication utilization.